This undated file image provided by Merck & Co. shows their new antiviral medication molnupiravir. An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will scrutinize data on the medication from drugmaker Merck. (Merck & Co. via AP, File)
November 30, 2021
Stories this photo appears in:
November 30, 2021 2:20 p.m.
FDA panel backs first-of-a-kind COVID-19 pill from Merck
A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy
LOCAL SAVINGS AD UNIT